CLOs on the Move

Novo Nordisk

www.novonordisk.com

 
At Novo Nordisk, we are driving change to defeat diabetes and other serious chronic conditions. Diabetes poses one of today`s biggest global health challenges. We work for a future where fewer people get diabetes, everyone with diabetes is diagnosed, and everyone who is diagnosed receives adequate treatment and can live a life with as few limitations as possible. Since the company was founded in Denmark more than 90 years ago, we have been changing diabetes. This heritage has given us experience and capabilities that also enable us to help people defeat other serious chronic conditions: haemophilia, growth disorders and obesity. ...
  • Number of Employees: 1K-5K
  • Annual Revenue: > $1 Billion

Executives

Name Title Contact Details
Marc Fishman
Vice President, Deputy General Counsel Profile
Brian Donnelly
Managing Assistant General Counsel Profile
Forrester Liddle
Head of Intellectual Property and Legal for Profile
Melissa DeHonney
Asst. General Counsel - Market Access and Public Affairs Profile
Denise Maher
Managing Assistant General Counsel - Employment Law and EEO Investigations Profile

Similar Companies

Sanovia

Sanovia s corporate vision is to deliver state-of-the-art products and services which allow its customers to take advantage of advanced technology to improve communications, improve resource utilization through automated workflow processes, advance the quality and appropriateness of care through the integrated use of automated best-practice pharmaceutical clinical guidelines, and control costs.

Sonic Packaging Industries

Sonic Packaging Industries is a Westwood, NJ-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Regernon Pharmaceuticals

Regernon Pharmaceuticals Inc. is a Tarrytown, NY-based company in the Healthcare, Pharmaceuticals, & Biotech sector.

The Harvard Drug Group

The Harvard Drug Group is a Livonia, MI-based company in the Healthcare, Pharmaceuticals, & Biotech sector.

Aeras Global TB Vaccine Foundation

Aeras is constantly producing new constructs that will also be made available following phenotypic, genotypic and stability characterization. Aeras is also glad to provide shigella carrier strains with capsids expressing TB antigens under similar